Status, sale and patenting of human genetic material: an international survey
- 1 May 1999
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 22 (1) , 23-26
- https://doi.org/10.1038/8735
Abstract
Following a decade of debate, the European Directive on the Legal Protection of Biotechnological Inventions was adopted by the European Parliament and the Council of the European Union on July 6, 1998. The Directive constitutes a legal and social policy landmark in biotechnology, taking an explicit position on the contentious issue of the patentability of higher life forms. It fails, however, to provide definitive statements on the legal status of human genetic material or the possibility of personal financial gain in relation to such material. An overview of the international, regional and national positions (as found in laws and official policy statements) on the status, commodification and patentability of human genetic material indicates that, although the Directive represents a consolidation of opinions, many issues remain unresolved.Keywords
This publication has 11 references indexed in Scilit:
- BiotechnologyPublished by Springer Nature ,1999
- DNA Studies Challenge the Meaning of RacePublished by American Association for the Advancement of Science (AAAS) ,1998
- Will Patent Fights Hold DNA Chips Hostage?Science, 1998
- Do EST patents matter?Trends in Genetics, 1998
- The Inscription of Life in Law: Genes, Patents, and Bio‐politicsThe Modern Law Review, 1998
- Group Identity and Human Diversity: Keeping Biology Straight from CultureAmerican Journal of Human Genetics, 1998
- Control of DNA Samples and InformationGenomics, 1998
- Can Patents Deter Innovation? The Anticommons in Biomedical ResearchScience, 1998
- Professional Disclosure of Familial Genetic InformationAmerican Journal of Human Genetics, 1998
- Disease gene patenting is a bad innovationMolecular Diagnosis, 1997